| Net Cash Provided by (Used in) Operating Activities |
$66,011 |
USD |
-69% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$7,311 |
USD |
95% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
700,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
100,071,075 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$912,459 |
USD |
294% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$13,035,433 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Issued |
7,568 |
shares |
0% |
Q2 2024 |
FY 2024 |
| Deferred Federal Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$23,410,726 |
USD |
0.1% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
7,568 |
shares |
0% |
Q2 2024 |
FY 2024 |
| Current State and Local Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Amortization of Intangible Assets |
$107,500 |
USD |
-15% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$13,035,433 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$23,872 |
USD |
-72% |
Q3 2024 |
Q1 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$78,638 |
USD |
-26% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |